hi again. Not sure about the spin not insight? Surely he described the action of the various products and their targets and their development. Would be very informative to a new investor if I didnt know most of this already. . Personally I'm thinking the fact they dont have a full time CEO and or CFO is probably the main reason they still only have 140 odd million shares on issue after 5 years, which I still find stunning. Most of these small pharma seem to have CEO CFO whatever else all on 400k + incentives per annum, I've certainly learned that the hard way. I was attracted by board members buying on market and stunned when I saw shares on issue. Said it before but at this stage I have never seen anything with this potential in 20 years. I said that in march I believe and since them I have been up around 300% and to me it hasnt even started yet. Hard to believe it is all just an illusion as you seem to believe, although obviously it still could be, wont know until phase 2 human trials. This certainly seems a little personal between you and James.
RCE Price at posting:
$1.31 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)